More Articles
As more individuals are being diagnosed with heart failure, finding effective treatment methods is a priority for physicians and patients. A new study published in the scientific journal Nature Communications may have found a way to…
In response to a study published in JAMA Cardiology last week about a decrease…
In the decade since Hurricane Katrina, cardiologists in New Orleans have noticed an uptick in the number of patients suffering from heart attacks.
An initial study conducted by researchers at Tulane Medical Center showed that there were in…
As sudden cardiac death among patients with heart failure remains a major concern in the U.S., a new study conducted by researchers from Virginia Tech aims to tackle the issue.
Steven Poelzing, an associate professor at the Virginia Tech…
A scientist from the University of Connecticut has created a technique to study heart tissues and identify heart disease. The method is similar to how physicians examine cancer tissue under a microscope.
J. Travis Hinson, MD, creates heart-…
Novartis has launched a social network called Together in HF for heart failure patients and caregivers.
Novartis…
Obesity is a risk factor for cardiovascular disease. But not all obesity is created equal—and that’s why it’s so hard to both treat and prevent.
Along with its precursor—being overweight—obesity is not one disease. Instead, much like cancer…
Epidemiological studies show that individuals who consume more fruits and vegetables reduce their risk of developing cardiovascular disease. But like most things, some fruits—and…
Jardiance, a medication designed to reduce the risk of cardiovascular death in adults with type 2 diabetes and cardiovascular disease, was approved by the U.S. Food and Drug Administration (FDA) this week, making it the first type 2 diabetes…
The Centers for Medicare and Medicaid Services (CMS) has approved a new specialty code for advanced heart failure and transplant cardiologists.
CMS…
Patients with chronic heart failure who received omecantiv mecarbil achieved plasma concentrations associated with improved cardiac function and decreased ventricular function, according to a randomized trial.
Lead researcher John R.…
The FDA granted Cardiac Dimensions an investigation device exemption for the company to begin a pivotal trial evaluating the Carillon mitral contour system to treat symptomatic functional mitral regurgitation associated with heart failure.
…
Three facilities receive CMS approval to perform destination therapy with ventricular assist devices
The Centers for Medicare and Medicaid Services (CMS) recently announced that three facilities had met its standards for destination therapy with ventricular assist devices.
The agency…
Since 2005, the mortality from myocarditis has decreased, although it remains a difficult disease to treat and diagnose, according to a recent review.
Lead researcher Stephane Heymans, MD, of Maastricht University Medical Centre in the…
A pooled analysis of four cohort studies found that patients who did not have hypertension, obesity and diabetes by 45 to 55 years old had up to an 86 percent lower risk of developing heart failure during their lifetime.
Lead researcher…
Genetics play a role in whether an individual develops heart disease. But they’re not the only determining factor. A new study found that good habits can overcome bad genetics in heart disease.
During the American Heart Association (AHA)…
A registry analysis found that the quality of care and one-year clinical outcomes for Medicare beneficiaries were similar at centers with low and high risk-adjusted 30-day heart failure readmission rates.
Lead researcher Ambarish Pandey, MD…
Untreated sleep apnea has been proven to cause or worsen heart disease—and according to a new study, it happens faster than previously thought.
Researchers at the University of…
After one year, the HeartLogic heart failure diagnostic service helped alert healthcare professionals of worsening heart failure in patients with cardiac resynchronization therapy defibrillator (CRT-D) systems, according to a multicenter,…
New research on the experimental drug ularitide, which is designed to decrease adverse effects of acute heart failure, has left cardiologists deciphering findings that are simultaneously disappointing and encouraging.
The findings were…
Hospital admissions for heart attacks in New Orleans are three times higher than before Hurricane Katrina, according to research presented at the American Heart Association’s Scientific Sessions 2016.
In the months following the disaster,…